JPMorgan Chase & Co. Trims UiPath (NYSE:PATH) Target Price to $19.00
UiPath (NYSE:PATH – Free Report) had its target price decreased by JPMorgan Chase & Co. from $28.00 to $19.00 in a report issued on Thursday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the healthcare company’s stock. Several other equities research analysts have also commented on the company. DA Davidson […]
More Stories
US, EU Sign Preliminary Partnership Deal on Critical Minerals
By Owen Evans The United States and the European Union signed a memorandum of understanding on April 24 for a...
DOJ Approves Firing Squads for Federal Death Penalty Cases
By Michael Clements The Department of Justice (DOJ) has authorized firing squads, electrocution, and gassing as a means of execution...
Trump Extends Jones Act Waiver for 90 Days to Ease Energy Crunch
By Tom Ozimek President Donald Trump has extended a waiver of the century-old Jones Act for 90 days, allowing foreign-flagged...
Canada Rescinds Digital Services Tax After Trump Halts Trade Talks
By Omid Ghoreishi The Canadian government is rescinding its digital services tax to avoid stalling trade talks with the United...
Trump Floats Taxpayer-Funded Takeover of Spirit Airlines, Selling for Profit
By Chris Summers President Donald Trump said on April 23 that a taxpayer-funded takeover of Spirit Airlines could be an...
Release Date for The Wonderfools Announced! Cast, Character, and Trailer
Netflix’s upcoming supernatural and comedy Korean drama, The Wonderfools, is ready to premiere soon. Kang Eun-kyung, known for series like...